Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Oncology Letters|May 20, 2017
Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomibNoriyoshi Iriyama, Katsuhiro Miura, Yoshihiro Hatta, et al.
International Journal of Clinical Oncology|October 12, 2011
Harmonization of molecular monitoring of chronic myeloid leukemia therapy in JapanChikashi Yoshida, Linda Fletcher, Kazuteru Ohashi, et al.
Virchows Archiv : an International Journal of Pathology|September 6, 2007
Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosisMakoto Sano, Masahiko Sugitani, Toshiyuki Ishige, et al.
Leukemia Research|January 23, 2017
Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study GroupNoriyoshi Iriyama, Michihide Tokuhira, Tomoiku Takaku, et al.
Leukemia & Lymphoma|August 26, 2017
Introduction of second-generation tyrosine kinase inhibitors may reduce the prognostic impact of high-risk patients, according to the European treatment and outcome study (EUTOS) scoreEriko Sato, Noriyoshi Iriyama, Michihide Tokuhira, et al.
European Journal of Haematology|September 21, 2022
von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet countsKazuhide Iizuka, Soji Morishita, Yuji Nishizaki, et al.
Case Reports in Oncology|June 29, 2023
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell TransplantationTakashi Hamada, Hiromichi Takahashi, Masaru Nakagawa, et al.
Virchows Archiv : an International Journal of Pathology|July 27, 2016
A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behaviorDaisuke Kurita, Kengo Takeuchi, Sumiko Kobayashi, et al.
Medical Oncology (Northwood, London, England)|February 15, 2018
Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phaseMichihide Tokuhira, Yuta Kimura, Keiji Sugimoto, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple MyelomaYurika Noguchi, Noriyoshi Iriyama, Hiromichi Takahashi, et al.
Pageof 13